U.S. Physical Therapy, Inc. (NYSE:USPH) CEO Christopher J. Reading sold 19,860 shares of the company’s stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $119.36, for a total value of $2,370,489.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

NYSE:USPH opened at $113.69 on Friday. U.S. Physical Therapy, Inc. has a one year low of $93.02 and a one year high of $129.65. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.39. The firm has a market capitalization of $1.53 billion, a PE ratio of 42.90, a P/E/G ratio of 3.65 and a beta of 1.15.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Thursday, May 2nd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.62 by $0.04. U.S. Physical Therapy had a return on equity of 19.09% and a net margin of 5.34%. The business had revenue of $116.23 million during the quarter, compared to analyst estimates of $114.12 million. The company’s revenue was up 7.3% compared to the same quarter last year. Sell-side analysts expect that U.S. Physical Therapy, Inc. will post 2.92 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 14th. Shareholders of record on Friday, May 17th will be paid a $0.27 dividend. The ex-dividend date of this dividend is Thursday, May 16th. This represents a $1.08 dividend on an annualized basis and a yield of 0.95%. U.S. Physical Therapy’s payout ratio is presently 40.75%.

Hedge funds have recently modified their holdings of the business. Bank of New York Mellon Corp boosted its holdings in shares of U.S. Physical Therapy by 3.1% during the 3rd quarter. Bank of New York Mellon Corp now owns 185,318 shares of the company’s stock valued at $21,979,000 after purchasing an additional 5,527 shares during the last quarter. AQR Capital Management LLC boosted its holdings in shares of U.S. Physical Therapy by 17.4% during the 3rd quarter. AQR Capital Management LLC now owns 5,626 shares of the company’s stock valued at $667,000 after purchasing an additional 832 shares during the last quarter. Teachers Advisors LLC boosted its holdings in shares of U.S. Physical Therapy by 1.7% during the 3rd quarter. Teachers Advisors LLC now owns 27,717 shares of the company’s stock valued at $3,287,000 after purchasing an additional 469 shares during the last quarter. Morgan Stanley boosted its holdings in shares of U.S. Physical Therapy by 80.4% during the 3rd quarter. Morgan Stanley now owns 96,651 shares of the company’s stock valued at $11,463,000 after purchasing an additional 43,074 shares during the last quarter. Finally, Vanguard Group Inc. boosted its holdings in shares of U.S. Physical Therapy by 5.9% during the 3rd quarter. Vanguard Group Inc. now owns 767,401 shares of the company’s stock valued at $91,014,000 after purchasing an additional 43,050 shares during the last quarter. Institutional investors and hedge funds own 99.58% of the company’s stock.

Several research firms have recently commented on USPH. Zacks Investment Research upgraded U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $127.00 price objective for the company in a research note on Friday, April 26th. Barrington Research restated a “hold” rating on shares of U.S. Physical Therapy in a research note on Friday, May 3rd. TheStreet upgraded U.S. Physical Therapy from a “c+” rating to a “b” rating in a research note on Friday, March 8th. William Blair began coverage on U.S. Physical Therapy in a research note on Thursday, March 7th. They issued an “outperform” rating and a $106.61 price objective for the company. Finally, ValuEngine lowered U.S. Physical Therapy from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, March 6th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $111.40.

ILLEGAL ACTIVITY WARNING: This report was published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://theolympiareport.com/2019/05/24/insider-selling-u-s-physical-therapy-inc-usph-ceo-sells-19860-shares-of-stock.html.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Article: What are trading strategies for the 52-week high/low?

Insider Buying and Selling by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.